logo

AMER MED S(NSDQ:AMMD)
American Medical Services is a leading independent company focused solely on supplying medical devices to physicians specializing in the treatment of urological disorders. The company manufactures and markets a broad and well-established line of proprietary products directly to urologists, with its principal focus on the three major urological disorders: incontinence, erectile dysfunction and prostate disease. With its reputation for quality and innovative products and relationships with urological surgeons, the company is well position to benefit from the growth in the urology market.positi
# Employees: 1205
Address: 10700 Bren Road West,Minnetonka,MN,USA
Phone: 952-930-6000
Fax: 952-930-6373
Website: www.americanmedicalsystems.com
Email: Info@AmericanMedicalSystems.com
Sector: Medical
Industry: MED PRODUCTS
Executive Officers
Ross A. Longhini (C.E.O.; Exec. V.P.; C.O.O.; Dir.)
Scott R. Etlinger (Sr. V.P.; Global Opera.)
Janet L. Dick (Sr. V.P.; Human Res.)
John F. Nealon (Sr. V.P.; Bus. Develop.)
Lawrence W. Getlin (Sr. V.P.; Compliance; Quality Systems & Legal,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/16/2010
Mean EPS (Next Qtr): $0.32
Mean EPS (Year): $1.13
Mean Estimate(Long Term): $14.00
P/E Ratio(Based on EPS estimate): 15.160
Number of Estimates: 9
Shares Performance
Period AMMD Compare to S&P
YTD 90.88 % 57.97 %
4 Weeks 7.92 % 6.76 %
12 Weeks 12.08 % 5.67 %
Shares Information
Analyst Coverage: Y
Avg Volume: 727493
Shares Outstanding: 74M
Market Cap: $1.27B
52 Week High: $17.93
52 Week Low: $8.25
P/E Ratio: 17.160
PEG Ratio: 1.080
Split: On 3/22/2005 AMMD split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: -31.03 %
EPS Growth in Last Year: 42.86 %
Sales Growth in Last Quarter: -2.50 %
Sales Growth in Last Quarter: 4.91 %
Financials
Qtr Book Value: $2.47
Cash Flow/Share: $12.50
Change in Payout Ratio: 0.000
Price/Sales: 2.510
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia